Cerus Investor Relations Material
Latest events
Q2 2025
Cerus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cerus Corporation
Access all reports
Cerus Corporation develops and markets blood safety technologies intended to reduce the risk of transfusion-transmitted infections. Its INTERCEPT platform is used to treat blood components such as platelets and plasma. The company serves blood centers, hospitals, and transfusion services. The company is headquartered in Concord, California, and its shares are listed on the NASDAQ.
Key slides for Cerus Corporation
Q3 2024
Cerus Corporation
Corporate Presentation
Cerus Corporation
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
CERS
Country
🇺🇸 United States